← Leaderboards
Catherine Digovich
Minutia, Inc.
$2,139,998
Attributed
$2,364,998
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2021–24$2M$1.5M$1M$500K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$2,364,998 · 3
By mechanism
R44$1,740,000 · 1
R43$624,998 · 2
Top collaborators
- Matthias Hebrok1 shared
- Sapna Puri1 shared
- Tuan Vo-Dinh1 shared
Others in their field
Other Emerging Leaders on “Novel Strategies”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Mark Marino · Venturewell$48,913,644
- Ted Ross · University Of Georgia$39,967,158
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Xinhua Li · Nano Terra, Inc.$29,432,783
Research focus
Novel StrategiesSuccessIsletNanosensorsStem CellsStressInsulin-Dependent Diabetes MellitusIn VivoMicrornasMonitorSensorSignal TransductionCell TransplantationBeta CellCell Replacement TherapyInsulinDesignIn VitroAllogenicIslets Of Langerhans TransplantationEnvironmentCellsResponseTechnology
Grant awards (4)
Monitoring graft responses to the transplant niche in allogeneic cell replacement therapy$870,000
R44 · FY2024 · DK · contact PI
Monitoring and increasing resilience of stem cell derived pancreatic islet cell grafts$324,998
R43 · FY2024 · DK · contact PI
Monitoring graft responses to the transplant niche in allogeneic cell replacement therapy$870,000
R44 · FY2023 · DK · contact PI
Real-time intracellular monitoring of microRNAs in human stem cell-derived insulin producing organoids$300,000
R43 · FY2021 · DK · contact PI